We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

19 hedge funds and large institutions have $14.7M invested in Nuvation Bio Inc Warrants in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% less ownership

Funds ownership: 1.91%1.84% (-0.07%)

14% less funds holding

Funds holding: 2219 (-3)

20% less capital invested

Capital invested by funds: $18.3M → $14.7M (-$3.68M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
5
Closed
3
Calls
$78K
Puts
Net Calls
+$78K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
EcoR1 Capital
California
$8.19M
6CM
2
683 Capital Management
New York
$1.56M
HCM
3
Highbridge Capital Management
New York
$733K
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$504K
BC
5
Boxer Capital
California
$504K
Franklin Resources
6
Franklin Resources
California
$504K
BlackRock
7
BlackRock
New York
$437K -$4.91K -2,165 -0.9%
CCA
8
Castle Creek Arbitrage
Colorado
$408K
DM
9
Deerfield Management
New York
$315K
Walleye Capital
10
Walleye Capital
New York
$308K
RSCM
11
Rock Springs Capital Management
Maryland
$253K
APM
12
Avidity Partners Management
Texas
$189K
GC
13
Greenlight Capital
New York
$189K
Citadel Advisors
14
Citadel Advisors
Florida
$139K -$193 -85 -0.1%
Victory Capital Management
15
Victory Capital Management
Texas
$128K -$2.97K -1,310 -2%
LGM
16
Logos Global Management
California
$126K
MA
17
MYDA Advisors
New York
$72K
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$66K
IP
19
Intellectus Partners
California
$47K -$3.02K -1,332 -5%
UBS Group
20
UBS Group
Switzerland
$4K -$20 -9 -0.5%
ACP
21
Acuta Capital Partners
California
-$242K -90,832 Closed
CC
22
Clearline Capital
New York
-$85K -33,271 Closed
MIM
23
Monashee Investment Management
Massachusetts
-$68K -26,666 Closed

NUVB.WS Hedge Fund Activity: Q4 2021 in Review

19 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q4 2021, worth a combined $14.7M — down 20% from $18.3M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NUVB.WS and 0 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.

The largest seller was Acuta Capital Partners, exiting entirely with an estimated $242K sold.

  • 19 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q4 2021, down from 22 in Q3 2021.
  • Funds reported $14.7M of Nuvation Bio Inc Warrants stock for Q4 2021, down 20% quarter-over-quarter.
  • 0 funds opened new Nuvation Bio Inc Warrants positions in Q4 2021 and 3 closed out, a net change of -3 holders.
  • The largest Nuvation Bio Inc Warrants seller in Q4 2021 was Acuta Capital Partners, an estimated $242K sold.

Based on aggregated 13F filings for Q4 2021.